02nd week of 2009 patent applcation highlights part 47 |
Patent application number | Title | Published |
20090011911 | Exercise soft pad with ventilation - An exercise soft pad with ventilation includes a pad body made of a foam material. The pad has a pad surface for its user to exercise thereon. The pad surface has several vent holes going through the pad body. Therefore, the hot air produced by the user exercising thereon can go out through the ventilation holes. | 2009-01-08 |
20090011912 | DEAD-SHAFT ROLLER WITH AEROSTATIC ROTARY UNION - A dead-shaft roller having a shaft and a roll with a fluid circulation passage therein, and at least two bearings support the roll on the shaft. A rotary union is positioned at least one end of the roll, possibly both. The rotary union has a rotatable sleeve and a non-rotating sleeve. The rotatable sleeve has a fluid conducting path therein, such that the fluid conducting path is in fluid communication with the fluid circulation passage in the roll. The non-rotating sleeve is positioned adjacent and internal to the rotatable sleeve. The non-rotating sleeve has a first fluid port therein such that the fluid conducting path is in fluid communication with the first fluid port at a first fluid transfer zone. At least two air bearings are present, mounted between the rotatable sleeve and the non-rotating sleeve, such that the air bearings are on opposite sides of the first fluid transfer zone. | 2009-01-08 |
20090011913 | Tire for material treatment system - The invention provides a tire and a roll wheel assembly used to crush material in a pulverizer including a generally toroidal body having a crushing surface on the outer periphery thereof. The crushing surface is configured and adapted to contact and crush the material within the pulverizer. At least one beveled surface is defined on an inner periphery of the body. The beveled surface is configured and adapted to engage a wedge disposed on a roller wheel of a roll wheel assembly to hold the tire on the roller wheel. The invention also provides a method of securing a tire to a roller assembly in a pulverizer for crushing material. | 2009-01-08 |
20090011914 | PROCESS FOR MANUFACTURING A TAMPER EVIDENT CONTAINER LID - A tamper evident and resistant container lid of the present invention includes a lid body configured to cover the opening of a base container having a top rim and a skirt extending from the lid. The skirt has an annular score line and an annular fold line extending therearound. An outer band of the skirt extends between the score line and the fold line, and an inner band folded inwardly to be in opposing relation to the outer band extends upwardly from the fold line to an upper free edge. When the container lid is sufficiently applied to the base container such that the second portion slides downwardly past a top rim of the base container, achieving a proper closure, an attempt to remove the lid will cause a plurality of sections of the inner band to engage the top rim and impede removal of the container lid from the base container. | 2009-01-08 |
20090011915 | LEAD-FREE FRITS FOR PLASMA DISPLAYS AND OTHER GLASS DEVICES UTILIZING GLASS SEALING MATERIALS - The invention is directed to lead-free glass frit compositions that can be used as sealing frits, the compositions being a blend of: (1) an alkali-ZnO—P | 2009-01-08 |
20090011916 | STRENGTHENED, PRESSABLE CERAMIC COMPOSITIONS FOR DENTAL PURPOSES - Pressable glass-ceramic compositions for dental purposes of the composition I, II or III | 2009-01-08 |
20090011917 | LEAD-FREE GLASS COMPOSITES WITH A LOW THERMAL EXPANSION COEFFICIENT - The glass composite has a linear thermal expansion coefficient α | 2009-01-08 |
20090011918 | Optical glass and optical element - An optical glass of the present invention has optical constants with a refractive index (nd) of 1.74 to 1.76 and an Abbe number (υd) of 45 to 49.5, contains SiO | 2009-01-08 |
20090011919 | PROCESS FOR PRODUCING HONEYCOMB STRUCTURE - A process for producing a honeycomb structure by obtaining clay from a cordierite-forming raw material containing an alumina source, a silica source, and a magnesia source; and forming the clay into a honeycomb shape, wherein a material having, in its volume particle size distribution, a 50 volume % particle size (V50) [μm] of 1 to 25 μm is used, as each of alumina source, silica source, and magnesia source; and a material having, in the volume particle size distribution of the whole cordierite-forming raw material, a ratio of 90 volume % particle size (V | 2009-01-08 |
20090011920 | GASIFIER REACTOR INTERNAL COATING - A gasifier comprising an interior wall on which a layer is applied or an interior wall protected by an assembly of blocks, said layer or said blocks having at least one region of a sintered material containing:
| 2009-01-08 |
20090011921 | Dielectric Porcelain Composition and Method for Production Thereof - A dielectric porcelain composition here contains as main components BaO, Nd | 2009-01-08 |
20090011922 | CERAMIC ANTENNA MODULE AND METHODS OF MANUFACTURE THEREOF - Circuit modules and methods of construction thereof that contain composite meta-material dielectric bodies that have high effective values of real permittivity but which minimize reflective losses, through the use of host dielectric (organic or ceramic), materials having relative permittivities substantially less than ceramic dielectric inclusions embedded therein. The composite meta-material bodies permit reductions in physical lengths of electrically conducting elements such as antenna element(s) without adversely impacting radiation efficiency. The meta-material structure may additionally provide frequency band filtering functions that would normally be provided by other components typically found in an RF front-end. | 2009-01-08 |
20090011923 | DIELECTRIC PORCELAIN COMPOSITION AND ELECTRONIC COMPONENT - The present invention provides a dielectric porcelain composition comprising 100 parts by weight of a barium titanate-based dielectric material and 4 to 10 parts by weight in total of Bi | 2009-01-08 |
20090011924 | SINTERED POLYCRYSTALLINE TERBIUM ALUMINUM GARNET AND USE THEREOF IN MAGNETO-OPTICAL DEVICES - A composition is provided that includes a plurality of calcined particles of terbium aluminum oxide having a mean particle domain size of between 30 and 600 nanometers. A translucent article having a surface includes polycrystalline terbium aluminum garnet having a mean grain size from 1 to 10 microns and light scattering inclusions of aluminum-rich oxide and/or terbium-rich oxide that are present at less than 2 surface area percent of the surface. A process for forming such an article involves sintering the above provided composition at a temperature between 1500° C. and 1700° C. to yield a sintered article. The article has improved translucency and even transparency as sintering is performed under vacuum at a temperature between 1610° C. and 1680° C. Hot isostatic pressing alone or in combination with article polishing also improves article translucency. | 2009-01-08 |
20090011925 | Method for producing catalytically active glass-ceramic materials, and glass-ceramics produced thereby - A catalytically active glass-ceramic and method for producing a catalytically active multi-phase glass-ceramic in which at least one catalyst precursor is mixed with a glass-ceramic precursor formulation to form a catalyst precursor/glass-ceramic precursor mixture. The catalyst precursor/glass-ceramic precursor mixture is then melted to form an amorphous glass material which, in turn, is devitrified to form a polycrystalline ceramic. The polycrystalline ceramic is then activated, forming a catalytically active multi-phase glass-ceramic. | 2009-01-08 |
20090011926 | PROCESS FOR PRODUCING DDR TYPE ZEOLITE MEMBRANE - A method for producing a DDR type zeolite membrane, comprising immersing a porous substrate in a raw material solution containing 1-adamantanamine, silica, and water; and carrying out a hydrothermal synthesis of DDR type zeolite in the presence of a DDR type zeolite seed crystal (seed crystal) to form a DDR type zeolite membrane on the surface of the porous substrate by making a content ratio of 1-adamantanamine to silica (1-adamantanamine/silica) in the range of 0.002 to 0.4 in terms of molar ratio and a content ratio of water to silica (water/silica) in the range of 10 to 500 in terms of molar ratio, and an average particle diameter of the seed crystal to 300 nm or less to provide a method for producing stably a DDR type zeolite membrane of uniform and thin membrane thickness with high gas permeability. | 2009-01-08 |
20090011927 | SELECTIVE CATALYTIC REDUCTION ON N2O - A gas stream containing nitrous oxide and ammonia is contacted with a catalyst composition containing a zeolite. N | 2009-01-08 |
20090011928 | PHOTOCATALYTIC METHODS FOR PREPARATION OF ELECTROCATALYST MATERIALS - The invention relates to methods of preparing metal particles on a support material, including platinum-containing nanoparticles on a carbon support. Such materials can be used as electrocatalysts, for example as improved electrocatalysts in proton exchange membrane fuel cells (PEM-FCs). | 2009-01-08 |
20090011929 | MULTINUCLEAR COMPLEX AND POLYMER THEREOF - To provide a multinuclear complex including at least one ligand L satisfying the following requirements (i) r (ii) and (iii), and a plurality of metal atoms in a molecule:
| 2009-01-08 |
20090011930 | Cerium Compositions and Methods of Making the Same - The present invention is directed to cerium compositions and methods for making such metal oxide compositions, specifically, such metal oxide compositions having high surface area, high metal/metal oxide content, and/or thermal stability with inexpensive and easy to handle materials. | 2009-01-08 |
20090011931 | Highly Active Slurry Catalyst Composition - The instant invention is directed to the preparation of a slurry catalyst composition. The slurry catalyst composition is prepared in a series of steps, involving mixing a Group VIB metal oxide and aqueous ammonia to form an aqueous mixture and sulfiding the mixture to form a slurry. The slurry is then promoted with a Group VIII metal. Subsequent steps involve mixing the slurry with a hydrocarbon oil, and combining the resulting mixture with hydrogen gas (under conditions which maintain the water in a liquid phase) to produce the active slurry catalyst. | 2009-01-08 |
20090011932 | Exhaust Gas-Purifying Catalyst and Method of Manufacturing the Same - An object of the present invention is to provide an exhaust gas-purifying catalyst that is less prone to cause a decrease in its activity even when used at high temperatures in an atmosphere whose oxygen concentration is high. An exhaust gas-purifying catalyst of the present invention includes a composite oxide of alkaline-earth metal and aluminum, and platinum, wherein at least a part of the composite oxide and at least a part of the platinum forms a solid solution. | 2009-01-08 |
20090011933 | Materials having crosslinked polyrotaxane and process for producing the same - A material having crosslinked polyrotaxane which has further improved swelling properties, especially one having a crosslinked polyrotaxane which changes in swelling property with change in pH; and a material having a crosslinked polyrotaxane which is responsive especially at a high speed to a change of the surrounding electric field. The materials have a crosslinked polyrotaxane comprising at least two polyrotaxane molecules which each comprises cyclic molecules, a linear molecule which includes the cyclic molecules in cavities of cyclic molecules in a skewered manner, and capping groups, each of which locates at each end of the linear molecule in order to prevent the dissociation of the cyclic molecules, the least two polyrotaxane molecules having been bound to each other through a chemical bonding between the cyclic molecules thereof, wherein the cyclic molecules have hydroxy groups (—OHs) and part of the hydroxy groups are substituted with a group having an ionic group. | 2009-01-08 |
20090011934 | Method for Controlling Aquatic Weeds - The present invention relates to a method for the control of aquatic weeds which comprises applying a herbicidally effective amount of at least one compound of formula (I) | 2009-01-08 |
20090011935 | Method of Inducing Tolerance of Plants Against Bacterioses - A method of inducing tolerance of plants against bacterioses which comprises treating the plants, the soil or seeds with an effective amount of a combination of a compound of the formula I | 2009-01-08 |
20090011936 | Cytochrome P450 genes conferring herbicide resistance - Compositions and methods for conferring herbicide resistance or tolerance to plants, plant cells, tissues and seeds are provided. Compositions include transgenic plants, plant cells, tissues, and seeds that have been transformed with a nucleic acid molecule encoding a cytochrome P450 or variant thereof that confers herbicide resistance or tolerance, alone or in combination with one or more additional nucleic acid molecules encoding polypeptides that confer desirable traits. In particular, the cytochrome P450 or variant thereof confers resistance or tolerance to HPPD inhibitors, benzothiadiazinones, sulfonylureas, and other classes of herbicides. The additional polypeptide may also confer resistance or tolerance to an herbicide, including HPPD inhibitors and other herbicides. Methods are also provided for the production and use of the herbicide resistant or tolerant plants, plant cells, tissues and seeds of the invention. | 2009-01-08 |
20090011937 | Use of Fungicides for Increasing the Quality and Optionally the Quantity of Oil-Plant Products - The present invention relates to the use of certain fungicides for increasing the quality and, if appropriate, the quantity of oil crop products. It also relates to the use of these fungicides for reducing the brittleness of the seed coats of seed oil crops. Furthermore, it relates to oil plant products which can be obtained from oil crops which have been treated with these fungicides, for example oils or seeds from oil crops which have been treated in this manner. Furthermore, it also relates to renewable fuels which comprise the oil according to the invention and/or reaction products thereof. Finally, it relates to a method of improving the combustion in engines and furnace installations, in which these are operated at least to some extent with a suitable oil crop product according to the invention. | 2009-01-08 |
20090011938 | NOVEL GLYPHOSATE-N-ACETYLTRANSFERASE (GAT) GENES - Methods and compositions for improving yield in a plant are provided. Methods of improving yield include treating plants with an effective amount of glyphosate, wherein the plant express at least two heterologous polypeptides that impart tolerance to glyphosate via distinct modes of action. In one non-limiting method, the first polypeptide has glyphosate N-acetyl transferase activity and the second polypeptide comprises a glyphosate-tolerant EPSPS polypeptide. | 2009-01-08 |
20090011939 | Method of Inhibiting Ethylene Production in Plants - Methods of inhibiting ethylene production in a plant are provided that involve contacting a plant or plant part with an inhibitor of 1-aminocyclopropane-1-carboxylic acid oxidase (ACCO). The methods can be used to delay fruit and vegetable ripening, flower opening, or senescence of cut flowers. Also described are kits including an ACCO inhibitor and a floral preservative. | 2009-01-08 |
20090011940 | System and method for using a vacuum core high temperature superconducting resonator - A system for resonating. In one aspect, the system may include a temperature controlled, vacuum chamber. The chamber may include a primary superconductive coil having first and second ends and wrapped around a first non-conductive cylindrical form, where each of the first and second ends of the primary superconductive coil is coupled to a terminal of a driver, a secondary superconductive coil having first and second ends and wrapped around a second non-conductive cylindrical form, where a first end is coupled to a ground, and a tertiary superconductive coil having first and second ends and wrapped around a third non-conductive cylindrical form, where a first end is connected to a top load and a second end is coupled to the second end of the secondary superconductive coil. In one aspect, the top load is connected to an electrode, at least a portion of the electrode is located outside the chamber, and the first non-conductive cylindrical form at least partially surrounds the second non-conductive cylindrical form. | 2009-01-08 |
20090011941 | Precursor of Nb3Sn Superconducting Wire Produced by Powder Process and Nb3Sn Superconducting Wire Produced by Powder Process - There is provided a Nb | 2009-01-08 |
20090011942 | Method of Manufacturing MgB2 Superconducting Wire - A method of manufacturing a superconducting wire is provided. A MgB | 2009-01-08 |
20090011943 | High throughput genome sequencing on DNA arrays - The present invention is directed to methods and compositions for acquiring nucleotide sequence information of target sequences using adaptors interspersed in target polynucleotides. The sequence information can be new, e.g. sequencing unknown nucleic acids, re-sequencing, or genotyping. The invention preferably includes methods for inserting a plurality of adaptors at spaced locations within a target polynucleotide or a fragment of a polynucleotide. Such adaptors may serve as platforms for interrogating adjacent sequences using various sequencing chemistries, such as those that identify nucleotides by primer extension, probe ligation, and the like. Encompassed in the invention are methods and compositions for the insertion of known adaptor sequences into target sequences, such that there is an interruption of contiguous target sequence with the adaptors. By sequencing both “upstream” and “downstream” of the adaptors, identification of entire target sequences may be accomplished. | 2009-01-08 |
20090011944 | METHOD AND TEST KIT FOR DETECTING NUCLEOTIDE VARIATIONS - The present invention is related to a method for a simultaneous determination of the relative amounts of more than one target polynucleotide sequence and nucleotide variations in said targets. The method is carried out by separating and recording single-stranded probes, which have hybridized to the targets and which are determined and distinguished by their defined properties including size and optional detectable label. The probes are complementary to a region in the target that has a sequence being contiguous to the nucleotide variations to be determined. After being hybridized with affinity-tagged targets, the probes are attached to a solid support and purified. The target probe hybrids are elongated using enzyme-assisted elongations. The elongated probes are recorded after release from the solid supports and the amount of each of the targets and their nucleotide variations and the ratio of modified and modified target polynucleotide sequences are calculated from the recorded results. Also disclosed is a test kit, which kit comprises in a packaged form devices equipments and reagents as well as instructions for carrying out the method. The method is useful for several diagnostic purposes. | 2009-01-08 |
20090011945 | Method For Making Microsensor Arrays For Detecting Analytes - The present invention provides a method and a device for high-throughput, simultaneous, and continuous detection of one or more analytes using a pin-printed chemical sensor array. Chemical sensors comprising [Ru(4,7-diphenyl-1,10-phenanthroline) | 2009-01-08 |
20090011946 | Use of Sequence Specific Polymers in Chemical Detection - A method for chemical detection is provided. In one aspect, the method comprises exposing a sample to a sequence specific polymer under conditions such that an analyte in the sample binds to the polymer. Binding of the analyte to the sequence specific polymer results in a change in a property of the sequence specific polymer that is transduced to a response transduction medium, which generates a detectable response. Another aspect provides a detection device comprising the sequence specific polymer and response transduction medium. | 2009-01-08 |
20090011947 | Detection Chip and Method for Detecting Substance Using Same - A detection chip comprises a substrate and a well-shaped reaction portion formed in the substrate, in which the well-shaped reaction portion comprises a bottom portion having a planar shape and a side portion the width between which is widen from the bottom portion toward an opening portion. | 2009-01-08 |
20090011948 | Structured Substrates for Optical Surface Profiling - This disclosure provides methods and devices for the label-free detection of target molecules of interest. The principles of the disclosure are particularly applicable to the detection of biological molecules (e.g., DNA, RNA, and protein) using standard SiO | 2009-01-08 |
20090011949 | Methods and devices based upon a novel form of nucleic acid duplex on a surface - Provided herein are biomolecular hybridization devices comprising a substrate with a permanently and covalently attached surface of functional groups and an adsorbed monolayer of unmodified, single-stranded oligonucleotides all of which are 10 to about 24 bases in length as a saturated film of constrained oligonucleotides on the surface via direct non-covalent phosphate-surface adsorptive contact of substantially all phosphate groups of each oligonucleotide. The constrained oligonucleotides are effective to dissociably hybridize to a complementary single-stranded nucleic acid with asymmetric, non-helical base pairing and without oligonucleotide dissociation from the surface of the device. Also, provided are methods for hybridizing solution-state target nucleic acids to probe nucleic acids and for identifying a nucleotide sequence to which a nucleotide-binding protein binds using the biomolecular hybridization devices. | 2009-01-08 |
20090011950 | METHOD FOR DETECTING ORAL SQUAMOUS-CELL CARCINOMA AND METHOD FOR SUPPRESSING THE SAME - An object of the present invention is to provide a method for detecting cancer through identification of genes exhibiting characteristic behavior in the cases of cancer such as oral squamous-cell carcinoma, and a cell growth inhibitor. The present invention provides a method for detecting cancer, which comprises detecting canceration including malignancy of a specimen through detection of at least one alteration of a gene existing in a chromosomal region 1q21, 2q24. 1-q24.2, 3p13, 7p11.2, 10p12.1, 11p5.4, 11p15.2, 11p13.3, 11q22, 11q23.3, 12p13, 12q24.31, 13q33.3-q34, 12q24.1, 19q13, or 22q12.1 in the specimen. | 2009-01-08 |
20090011951 | Method of Gene Screening With Yeast Having Ergosterol Synthase Undergoing Inducible Expression - An expression of an ergosterol biosynthetic enzyme such as ERG6 and ERG3 is regulated with an inducible promoter, and transformation is performed in a state where the enzyme is expressed, and then screening or assay of drug-resistant colonies is performed in a state where the expression of the enzyme is repressed. | 2009-01-08 |
20090011952 | Chip assay having improved efficiency - The chip includes electrodes on a substrate. The electrodes include a working electrode, a reference electrode, and a counter electrode. The reference electrode is constructed so as to not have an intrinsic potential. A self-assembly monolayer is positioned on the reference electrode. The self-assembly monolayer includes spacers and active probes. The active probes are configured to have a higher affinity for a capture probe than the spacers have for the capture probe. | 2009-01-08 |
20090011953 | Methods and apparatuses for preparing a surface to have catalytic activity - The invention provides methods and apparatuses that utilize mass spectrometry for preparation of a surface to have catalytic activity through molecular soft-landing of mass selected ions. Mass spectrometry is used to generate combinations of atoms in a particular geometrical arrangement, and ion soft-landing selects this molecular entity or combination of entities and gently deposits the entity or combination intact onto a surface. | 2009-01-08 |
20090011954 | Thin Sheet for Retaining Biomolecules - This invention has application in a variety of biological and biochemical fields. The invention describes a thin sheet or sheets of flexible material with surface characteristics that provide an environment for retaining biological molecules. The flexible nature of the thin sheet of material permits the use of continuous preparation, processing and analysis techniques involving more compact and less complex equipment. The invention also describes a lamination of a thin sheet of flexible material to a substantially rigid second substrate so that the combination can be processed by existing equipment. The thin sheet of flexible material may be perforated prior to lamination in order to establish distinct wells in the surface of the lamination. | 2009-01-08 |
20090011955 | Method for Localization of Nucleic Acid Associated Molecules and Modifications - The present invention relates to a method for the localization of at least one molecule associated with, or site of interest in, a sample nucleic acid, comprising the steps—Bringing at least one reporter complex, comprising at least one binding part showing specific binding to the molecule or the site of interest and at least one reporter nucleic acid, into contact with the sample nucleic acid,—Fragmenting the sample nucleic acid,—Enzymatically ligating the reporter complex nucleic acid(s) to the sample nucleic acid, and—Detecting the hybrid ligation product. The invention also relates to libraries made with the method as well as microarrays of such libraries. | 2009-01-08 |
20090011956 | Versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways - The present invention relates generally to programming of biomolecular self-assembly pathways and related methods and constructs. A versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways for a wide variety of dynamic functions, reaction graphs for specifying pathways, and methods of using the hairpin motif are provided. | 2009-01-08 |
20090011957 | Ligational encoding using building block oligonucleotides - The present invention in one aspect relates to a method for synthesizing a bifunctional complex comprising a molecule and an identifier polynucleotide identifying at least some of the chemical entities which have participated in the synthesis of the molecule in accordance with the methods of the present invention. The invention also relates to a library of different bifunctional complexes. The library of the invention can be used e.g. for identifying drug leads. Furthermore, the present invention is based on the principle that chemical entities initially provided on a building block oligonucleotide (i.e. a building block having an oligonucleotide part which is linked to a chemical entity) can be brought into reactive proximity without the use of a template comprising a set of covalently linked codons. Also, the present invention allows reaction of chemical entities when the chemical entities are linked to a single stranded identifier polynucleotide obtained by covalently linking the oligonucleotide parts (oligonucleotide identifiers) of the building blocks. The single stranded identifier polynucleotides differs from template directed synthesis methods employing codon and anti-codon hybridisation between a template and one or more transfer units, i.e. methods wherein e.g. reactive units on transfer units are reacted while the anti-codon of the transfer units are hybridised to template codons. | 2009-01-08 |
20090011958 | PROCESS FOR IMMOBILIZING ORIENTATION-CONTROLLED PROTEIN AND PROCESS FOR ARRAYING AND IMMOBILIZING PROTEIN USING THE SAME - This invention provides a process for effectively producing an immobilized protein that is immobilized only at the carboxy terminus. This is a process for immobilizing on a carrier for immobilization a protein represented by general formula (1): | 2009-01-08 |
20090011959 | Method for preparing single-stranded DNA libraries - This invention relates to methods of generating single stranded DNA libraries for use in amplification and sequencing reactions. In various aspects, the disclosed methods include: fragmenting DNA; polishing the fragments' ends; ligating the fragments to universal adaptors; performing strand displacement and extension of the nicked fragments; purifying the double-stranded ligation products; capturing the double-stranded ligation products onto a solid support; and isolating single stranded DNA library fragments, and binding these fragments to another solid support. | 2009-01-08 |
20090011960 | DRILLING FLUID COMPOSITION COMPRISING HYDROPHOBICALLY ASSOCIATING POLYMERS AND METHODS OF USE THEREOF - The present disclosure relates to drilling fluids for use in bitumen recovery from oil sands. In particular, the disclosure relates to a drilling fluid composition containing hydrophobically associating polymers which encapsulate the bitumen, and a method and use of the composition. | 2009-01-08 |
20090011961 | Lubricant compositions stabilized with styrenated phenolic antioxidant - Compositions are disclosed that comprise a lubricant, at least a first antioxidant and an optional second antioxidant, the first antioxidant being a styrenated phenolic antioxidant and the optional second antioxidant a secondary diarylamine for synergistic antioxidant action. Also disclosed is a method of increasing the oxidation stability of lubricating oils comprising: adding thereto at least a first antioxidant and, optionally, a second antioxidant, the first antioxidant being a styrenated phenolic antioxidant and the optional second antioxidant a secondary diarylamine. | 2009-01-08 |
20090011962 | FRICTION MATERIAL - To provide a friction material with an excellent balance for both service brake and parking brake usage that satisfies the required performance for the service brake and improves the static coefficient of friction for the parking brake. The friction material comprising a fibrous base material, a friction modifier, and a binder, wherein said friction modifier comprises 2-20 volume % of cashew dust, 10-25 volume % of a rubber composition, and 2-5 volume % of a solid lubricant, a total volume of the cashew dust and the rubber composition is 30 volume % or less, and said friction modifier does not use graphite because it can cause the reduction of the coefficient of friction during the parking brake operation. | 2009-01-08 |
20090011963 | TRUCK FLEET FUEL ECONOMY BY THE USE OF OPTIMIZED ENGINE OIL, TRANSMISSION FLUID, AND GEAR OIL - The lubricant system of the present disclosure comprises an engine oil comprising at least one additive chosen from a viscosity index improver, a dispersant, a detergent, an antioxidant, and an antiwear compound; a transmission fluid comprising at least one additive chosen from a dispersant and a pour-point depressant; and a gear oil comprising at least one additive chosen from a viscosity index improver, an extreme pressure agent, and a dispersant. There is also disclosed a method of improving fuel economy of a vehicle comprising providing to the vehicle the disclosed lubricant system. | 2009-01-08 |
20090011964 | Lubricants Containing Multifunctional Additive Packages Therein for Improving Load-Carrying Capacity, Increasing Surface Fatigue Life and Reducing Friction - The present invention provides a composition for improving load carrying capacity, extreme pressure performance, surface fatigue life, and other performance characteristics of a lubricant. The composition includes a base stock and a combination of two, three, or all of a friction modifier, and antiwear additive, an extreme pressure additive, and a surface fatigue life modifier. The present invention further provides a method for improving the performance characteristics of a lubricant. The method includes a step of mixing a lubricant with the above-described multifunctional lubricant additive composition or mixing a lubricant base stock with the above-described multifunctional lubricant additive composition. | 2009-01-08 |
20090011965 | LUBRICANT FOR METALLIC MATERIAL WORKING AND A METHOD OF PRESS WORKING A METALLIC MATERIAL - [Object] To provide a lubricant for metallic material working and a method of press working a metallic material that makes it possible to improve the working accuracy of a press worked product and prolong the life of the die assembly beyond prior levels of life. [Solution] A lubricant for metallic material working comprises a mixture of a sulfur-based extreme pressure agent, an organic zinc compound, a calcium-based additive, and an ester compound, with lubricant base oil. The sulfur-based extreme pressure agent has a sulfur content of 5% by weight or higher based on the total weight of the lubricant. The organic zinc compound has a zinc content of 0.5% by weight or higher based on the total weight of the lubricant. The calcium-based additive has a calcium content of 0.5% by weight or higher based on the total weight of the lubricant. And the ester compound occupies a content of 1.0% by weight or higher based on the total weight of the lubricant. Additionally, the solution includes a method of press working a metallic material that employs such a lubricant. | 2009-01-08 |
20090011966 | Lubricating Oil Composition - A lubricating oil composition having a total base number of more than 15 mg KOH/g, as determined by ASTM D2896, and including at least 40 mass % of an oil of lubricating viscosity; at least one detergent; and at least one compound of the formula (I) and/or formula (II): | 2009-01-08 |
20090011967 | Cleaning solutions including nucleophilic amine compound having reduction and oxidation potentials - A composition for removing resists and etching residue from substrates containing at least one nucleophilic amine compound having oxidation and reduction potentials, at least one organic solvent, water and, optionally, a chelating agent is described. The chelating agent is preferred to be included since it provides added stability and activity to the cleaning composition so that the composition has long term effectiveness. If a chelating agent is not present, the composition, while providing for adequate stripping and cleaning upon initial use of the composition following mixing, has only short term stability. In this latter instance, the nucleophilic amine compound and organic solvent components of the composition preferably are maintained separate from each other until it is desired to use the composition. Thereafter, the components are combined. Following use of the composition, the non-used portion of the composition can be disposed of or be reactivated by the addition of a chelating agent. | 2009-01-08 |
20090011968 | Upper engine cleaning adaptors used to connect a pressurized unit containing an upper engine cleaner to the vehicles plenum - For decades the slow accretion of carbonaceous deposits on the upper cylinder areas of the internal combustion engines has acted to impair optimum performance and to significantly reduce gasoline or Diesel mileage per gallon. It has now been discovered that these formerly rather intractable engine deposits can be efficiently removed by dispersing and dissolving them through the use of optimized mixtures of polar protic and dipolar aprotic solvents that have the essential capability of acting in concert synergistically. For practical reasons these solvents must have a melting point higher than about 41° F. (5° C.). The finished product must also have a dielectric constant of about 20 and a pH value of at least 11.0 at 77° F. (25° C.). These parameters are considered vital to success. For example, in a test using a blend with a dielectric constant of 15, the removal of the carbonaceous deposits was either de minimus or very limited, even at pH values of 12.0 at 77° F. (25° C.) or higher. However, at a dielectric constant of 20 the degree of removal was quite satisfactory. Preferred compositions of this invention may be utilized in the form of self pressurized (aerosol) dispensers. | 2009-01-08 |
20090011969 | Method for Cleaning Metal Parts - The invention relates to a method for cleaning metal parts, according to which the metal parts are treated with a compound of the formula (1) | 2009-01-08 |
20090011970 | LAUNDRY MULTI-COMPARTMENT POUCH COMPOSITION - This invention relates to a laundry pouch made from a water-soluble film and having at least two compartments, containing a solid component and a liquid component, wherein the solid phase contains a peroxide source and the liquid phase contains bleach activator. The present invention also relates to a method for treating laundry by placing the pouch, according to the present invention, in the drum of the washing machine. | 2009-01-08 |
20090011971 | METHOD OF TREATING LAUNDRY - The present invention provides a method of treating fabrics by placing a multi-compartment pouch in the drum of the washing machine. Said pouch is made from a water-soluble film and have at least two compartments. | 2009-01-08 |
20090011972 | Surfactant for Fine-Bubble Formation - The present invention has its object to provide a surfactant which makes it possible to obtain microbubbles with ease, and is effective to render the microbubbles obtained stable for a long period of time. The present invention relates to a surfactant for microbubble formation
| 2009-01-08 |
20090011973 | SOLIDIFICATION MATRIX INCLUDING A SALT OF A STRAIGHT CHAIN SATURATED MONO-, DI-, AND TRI- CARBOXYLIC ACID - A solidification matrix includes a straight chain saturated carboxylic acid salt, sodium carbonate, and water. The straight chain saturated carboxylic acid salt is selected from a salt of a mono-, di-, or tri-carboxylic acid. The solidification matrix may be used, for example, in a solid detergent composition. | 2009-01-08 |
20090011974 | Scavenger Receptor B1 (Cla-1) Targeting for the Treatment of Infection, Sepsis and Inflammation - This invention relates to methods and compositions for the treatment of sepsis, inflammation or infection. In particular, the invention concerns the use of molecule(s) that target SR-BI, which is also referred to as CLA-1 (SR-BI/CLA-1), to treat sepsis, bacterial and viral infections, and inflammatory diseases. SRB I/CLA- | 2009-01-08 |
20090011975 | TARGETED BONE MARROW PROTECTION AGENTS - The invention provides a method of inhibiting cell death in a mammal. The method comprises administering to a mammal an effective amount of a composition comprising a cell protection factor covalently linked to a bone targeting agent via a linkage that is cleaved under physiological conditions, whereby the cell protection factor is released from the bone targeting agent in vivo to inhibit cell death. The invention further provides a compound comprising a cell protection factor covalently attached to a bone targeting agent via a linker that is cleaved under physiological conditions. | 2009-01-08 |
20090011976 | Stable Formulations Of Peptides - Stable pharmaceutical composition comprising insulinotropic peptide and basal insulin. | 2009-01-08 |
20090011977 | Novel Lipopeptides as Antibacterial Agents - The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds. | 2009-01-08 |
20090011978 | Use of Surfactant Preparations for the Treatment of Surgical Adhesions - The invention describes the use of surfactant comprising phospholipids and pulmonary surfactant proteins for the treatment of surgical adhesions. | 2009-01-08 |
20090011979 | IMMUNOMODULATORY PROTEIN AND USEFUL EMBODIMENTS THEREOF - The invention generally features the use of Yaba monkey tumor virus nucleic acid molecules and polypeptides for the treatment or prevention of immunoinflammatory disorders. | 2009-01-08 |
20090011980 | Method of Treating Parkinson's Disease in Humans by Direct Infusion of Glial Cell-Line Derived Neurotrophic Factor Into the Zona Incerta - A method of treating Parkinson's disease in humans is disclosed, wherein glial cell-line derive neurotrophic factor (GDNF) is chronically administered directly to the SNc and at least one subthalamic region or, alternatively, to the SNc, at least one sub thalamic region, and at least one putaminal region of the brain of a human in need of treatment thereof. In one aspect of the present invention the GDNF is infused directly into at least one caudal zona incerta and at least one postero-dorsal putamen of the brain through indwelling intraparenchymal brain catheters connected to an implantable pump. | 2009-01-08 |
20090011981 | Novel Inhibitors of Angiogenesis - The present invention provides novel inhibitors of angiogenesis. The invention relates to PF4var1 and fragments and modifications thereof with anti-angiogenic activity. Therefore, the present invention relates to the use of said proteins and peptides as a medicine, more in particular for the treatment or prevention of angiogenesis or for the manufacture of a medicament for the prevention or treatment of angiogenic diseases. The invention also provides pharmaceutical compositions comprising said proteins and peptides and method of preventing or treating angiogenic disorders. | 2009-01-08 |
20090011982 | Flagellin Related Polypeptides and Uses Thereof - The use of flagellin and flagellin related polypeptides for the protection of mammals from the effects of apoptosis is described. | 2009-01-08 |
20090011983 | 186 Human Secreted Proteins - The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins. | 2009-01-08 |
20090011984 | Biotin-binding receptor molecules - The subject invention pertains to a transmembrane protein capable of binding to biotinylated molecules, the protein comprising a cytoplasmic domain, a membrane-spanning domain and an extracellular domain, wherein the extracellular domain comprises biotin-binding activity, and methods of use. The protein can be expressed in a cell, thereby targeting a biotinylated drug. | 2009-01-08 |
20090011985 | GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject. | 2009-01-08 |
20090011986 | Thiosuccinic Acid Derivatives and the Use Thereof - The present invention relates to compounds of the Formula (I), wherein X | 2009-01-08 |
20090011987 | Use of Glp-2 for the Treatment of Ischemia-Reperfusion Injury - The present invention relates, inter alia, to the use of GLP-2 compounds in the treatment of ischemia-reperfusion injury in a subject. | 2009-01-08 |
20090011988 | METHOD FOR TREATING CARTILAGE DISORDERS - The present invention relates to a method for the treatment of a cartilage disorder, including cartilage damaged by injury or degenerative cartilagenous disorders. The method involves contacting the cartilage with an IGF-1 analog with altered affinity for IGF-binding proteins (IGFBPs) or an IGFBP displacer peptide that prevents the interaction of an IGF with an IGFBP and does not bind to a human IGF receptor. | 2009-01-08 |
20090011989 | Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease - The present invention provides a method for treating structural heart disease in a subject, comprising administering an effective amount of an inhibitor of CaMKII to the subject, whereby the administration of the inhibitor treats the structural heart disease in the subject. Also provided are transgenic animal models for treating structural heart disease. Further provided is a means of screening for a compound that can treat structural heart disease. | 2009-01-08 |
20090011990 | CARBOHYDRATE FRACTION AND USE THEREOF FOR A FLAT POSTPRANDIAL GLUCOSE RESPONSE - The invention relates to a combination of heat-treated nutritional composition having a carbohydrate fraction comprising a) 5-30 wt % of one or more monosaccharides selected from galactose, ribose and mannose; b) carbohydrates capable of providing b1) sustained release glucose and b2) rapidly available glucose; c) optionally fructose; d) glucose-containing disaccharides other than maltose and sucrose; and e) optionally sugar polyols. The invention also pertains to the use of such a heat-treated nutritional composition for controlling glucose levels in blood and/or tissue, especially for preventing and/or treating diabetics, insulin-resistance, obesity, postprandial glucose response, metabolic syndrome, syndrome X, hyperglycemia, hypertriglyceridemia, hyperinsulinemia, dyslipidemia, dysfibrinolysis and/or disorders associated with major surgery or trauma. | 2009-01-08 |
20090011991 | Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis - The fluorinated curcuminoid (3,5-bis-(2-fluorobenzylidene)-piperidin-4-one-acetate is about ten times more effective at arresting the growth of tumor cells than cisplatin. Conjugates for delivering a cytotoxic compound, such as a curcuminoid, specifically to cancer cells and to the vascular endothelial cells that nourish solid tumors, and methods of making and using thereof are described herein. The conjugate contains a cytotoxic compound bound to a protein such as in factor VIIa that retains high affinity for the surface protein tissue factor. The cytotoxic compound is bound to the protein via a linker and a hydrolyzable bond. Upon complexation, the resulting heterodimer is endocytosed and the drug is subsequently liberated inside the target cell via proteolytic cleavage. | 2009-01-08 |
20090011992 | Human Coagulation Factor VII Polypeptides - The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment. | 2009-01-08 |
20090011993 | Novel strategies for delivery of active agents using micelles and particles - The present invention provides biodegradable particles (e.g., three-dimensional particles) and micelles which can be used to encapsulate active agents for delivering to a subject. The present invention further provides methods for producing and delivering such particles and micelles. Additionally, the invention provides vaccination strategies that encompass the use of the novel particles and micelles. | 2009-01-08 |
20090011994 | NON-BASIC MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS AND METHODS - The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I | 2009-01-08 |
20090011995 | PRODUCTION OF A SOLUBLE NATIVE FORM OF RECOMBINANT PROTEIN BY THE SIGNAL SEQUENCE AND SECRETIONAL ENHANCER - The present invention is drawn to a method for enhancing secretional efficiency of a heterologous protein using a secretional enhancer consisting of a modified signal sequence which comprises the N-region of a signal sequence and/or a hydrophobic fragment of the said signal sequence comprising the said N-region and/or the hydrophilic polypeptide. The method of the present invention can be used not only for production of recombinant heterologous proteins by inhibiting insoluble precipitation and enhancing secretional efficiency of the recombinant protein into the periplasm or the extracellular fluid and but also for transduction of therapeutic proteins by enhancing membrane-permeability of the recombinant protein using a strong secretional enhancer. | 2009-01-08 |
20090011996 | DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS - Compositions for conferring protection against Equus caballus papillomavirus (EcPV) and Bovine papillomavirus (BPV) infection in a subject are provided and include a virus-like particle assembled from an EcPV L1 protein and virus like particle assembled from a BPV L1 protein. Methods for protecting a subject against EcPV and BPV infection are further provided and include administering to the subject a composition comprised of a virus-like particle assembled from an EcPV L1 protein and virus like particle assembled from a BPV L1 protein. Methods of diagnosing EcPV and/or BPV infection in a subject are also provided and include providing a virus-like particle assembled from a papillomavirus L1 protein selected from an EcPV L1 protein and a BPV L1 protein; contacting the virus-like particle with serum from the subject; and identifying the subject as having an infection if an antibody capable of binding the virus-like particle is detected in the serum. | 2009-01-08 |
20090011997 | BIFUNCTIONAL HORMONE AND USES THEREOF - A bifunctional hormone exhibiting an alpha-MSH activity and a natriuretic peptide activity is described. The bifunctional hormone comprises for example a first domain having alpha-MSH related hormonal activity covalently linked to a second domain having natriuretic peptide related hormonal activity. The bifunctional hormone of the present invention is useful for example for the prevention and/or treatment of renal related diseases or conditions, such as acute renal failure (ARF) or acute kidney injury (AKI). | 2009-01-08 |
20090011998 | CALCIUM-INFLUX INHIBITORY FACTOR AND METHOD OF ISOLATION THEREOF - A purified factor isolated from human milk is provided. The factor is capable of inhibiting calcium-influx activity in polymorphonuclear leukocytes. A method for purification of the factor is also provided. | 2009-01-08 |
20090011999 | ORALLY ACTIVE ANDROCTONUS AMOREUXI PESTICIDAL BIOPEPTIDES - The present invention provides compositions and methods for orally active | 2009-01-08 |
20090012000 | Anti-Viral Peptide and Use Thereof - Disclosed is an anti-viral peptide which non-naturally occurs and is artificially synthesized. The peptide has at least one unit of the following amino acid sequence (a) and at least one unit of the following amino acid sequence (b) or (c): (a) an amino acid sequence constituted by at least five contiguous amino acid residues which is known as a nuclear localization sequence (NLS) or an amino acid sequence having a partial modification in the NLS; (b) a conserved sequence of VAP which is an endoplasmic reticulum protein or an amino acid sequence having a partial modification in the conserved sequence; and (C) an amino acid sequence which is known as a FFAT motif found in various lipid-binding proteins or an amino acid sequence having a partial modification in the amino acid sequence. | 2009-01-08 |
20090012001 | LIPID METABOLISM-IMPROVING AGENT - The present invention relates to an agent for improving lipid metabolism, a food/drink, and a feed, containing αs-casein as an active ingredient thereof. In addition, the present invention relates to an agent for suppressing body weight gain, an agent for reducing body fat, and an agent for reducing blood lipid, containing the agent for improving lipid metabolism. | 2009-01-08 |
20090012002 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING PEPTIDES, USES AND TREATMENT PROCESSES - The present invention has as an aim a cosmetic and/or dermatological and/or pharmaceutical composition comprising, as an active ingredient, at least a peptide of sequence X | 2009-01-08 |
20090012003 | POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 - The present invention involves the identification and preparation of vascular endothelial growth factor-E (VEGF-E). VEGF-E is a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1. VEGF-E has homology to VEGF including conservation of the amino acids required for activity of VEGF. VEGF-E can be useful in wound repair, as well as in the generation and regeneration of tissue. | 2009-01-08 |
20090012004 | HLA binding peptides and their uses - The present invention provides the means and methods for selecting immunogenic peptides and the immunogenic peptide compositions capable of specifically binding glycoproteins encoded by HLA alleles and inducing T cell activation in T cells restricted by the allele. The peptides are useful to elicit an immune response against a desired antigen. The immunogenic peptide compositions of the present invention comprise immunogenic peptides having an HLA binding motif, where the peptide is from a target antigen. Target antigens of the present invention include prostate specific antigen (PSA), hepatitis B core and surface antigens (HBVc, HBVs) hepatitis C antigens, Epstein-Barr virus antigens, melanoma antigens (e.g., MAGE-1), human immunodeficiency virus (HIV) antigens, human papilloma virus (HPV) antigens, Lassa virus, | 2009-01-08 |
20090012005 | Use of an angiotensin IV antagonist to treat insulin resistance or cardiovascular risk related to metabolic syndrome - The present invention relates to the use of an angiotensin IV antagonist that decreases the effects on angiotensinogen expression of angiotensin IV in vascular smooth muscle cells for preparing a drug to treat or prevent type II diabetes, insulin resistance or cardiovascular risk related to metabolic syndrome, as well as to pharmaceutical compositions comprising one such antagonist. | 2009-01-08 |
20090012006 | Par-2 Antagonists - Compounds represented by the general formula (1) or salts thereof or solvates of both; PAR-2 antagonists containing the compounds; and preventive or therapeutic agents for PAR-2 related diseases containing the antagonists as the active ingredient: (1) wherein R | 2009-01-08 |
20090012007 | Mimetic Peptides and the Use Thereof in the Form of 20S, 26S and Immunoproteasome Inhitibors - The present invention relates to peptide-mimetic compounds, the synthesis and use thereof fort he inhibition of proteasomes and the induction of apoptosis in tumour cells. The present invention furthermore relates to pharmaceutical compositions comprising the compounds and the use of the compounds for a treatment of diseases, in particular cancer and neurodegenerative diseases. | 2009-01-08 |
20090012008 | Pharmaceutical Composition for Photodynamic Therapy and a Method for Treating Oncological Diseases by Using Said Composition - The present invention relates to the field of medicine, particularly to oncology and provides a pharmaceutical composition intended for the photodynamic therapy of malignant tumors, comprising a therapeutically effective amount of at least one of derivatives of fullerene C | 2009-01-08 |
20090012009 | Composition and Method for Treating Inflammatory Disease - A method of treating inflammatory diseases, and compositions and compounds therefor are described. More particularly, a method of treating inflammatory disease states with vitamin-hapten conjugates is described. | 2009-01-08 |
20090012010 | Amino acid derivatives as calcium channel blockers - Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds containing both an amino acid functionality and multiple aromatic rings are disclosed of the general formula (1) where X is benzhydryl, or an aromatic or heteroaromatic ring. | 2009-01-08 |